种族而非丙肝共感染影响当代透析HIV阳性者生存
研究利用全国透析提供者数据,比较5348例HIV阳性、1863例HIV/HCV共感染与HIV/HCV阴性参照组的透析生存。种族显著修饰HIV及HIV/HCV感染对死亡率的影响:白种人中HIV感染未增加死亡风险(HR 1.03,95%CI 0.91-1.16),但HIV/HCV共感染增加(HR 1.48,95%CI 1.18-1.87);非白种人中HIV感染(HR 1.44,95%CI 1.37-1.52)和共感染(HR 1.71,95%CI 1.60-1.84)均与更高死亡率显著相关。
要点
- 白种人HIV感染者透析生存与阴性参照无显著差异。
- 非白种人HIV感染及HIV/HCV共感染均显著增加透析死亡风险。
- HIV/HCV共感染在白种人和非白种人中均与生存受损相关。
核心结论
- 在广泛使用抗逆转录病毒治疗的时代,HIV感染仍与非白种人透析生存显著降低相关。
- HIV/HCV共感染无论种族或族裔均与透析生存受损相关。
研究设计与样本
- 利用全国透析提供者详细数据,通过行政编码和抗逆转录病毒药物处方确定HIV状态,通过常规血清学确定HCV共感染状态。
- 比较5348例HIV阳性组、1863例HIV/HCV共感染组与HIV/HCV阴性参照组的透析生存。
- 采用多变量模型分析,并使用倾向性评分进行二次分析。
主要发现
- 种族显著修饰HIV及HIV/HCV感染对死亡率的影响。
- 白种人中HIV感染未与死亡风险增加相关(HR 1.03,95%CI 0.91-1.16),HIV/HCV共感染与死亡风险增加相关(HR 1.48,95%CI 1.18-1.87)。
- 非白种人中HIV感染(HR 1.44,95%CI 1.37-1.52)和HIV/HCV共感染(HR 1.71,95%CI 1.60-1.84)均与更高死亡率显著相关。
- 倾向性评分二次分析结果相似。
- 参照组中位随访645天(IQR 230-1323),HIV阳性组772天(IQR 276-1623),共感染组777天(IQR 334-1665)。
临床怎么用
- 对非白种人HIV感染者启动透析时应加强风险评估与随访管理。
- 对HIV/HCV共感染的透析患者应关注生存受损风险并优化综合照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Individuals with HIV infection are at elevated risk of developing end-stage renal disease. However, their outcomes after starting chronic dialysis in the contemporary era of widespread antiretroviral therapy are not well described. Using detailed data from a national dialysis provider, we determined HIV status by administrative codes and antiretroviral medication prescriptions, with hepatitis C virus (HCV) co-infection status provided by routinely measured serology. The survival on dialysis among 5348 individuals in the HIV+ group and 1863 HIV+/HCV+ individuals to a HIV-/HCV- reference cohort was compared. Race significantly modified the effect of HIV and HIV/HCV infection on mortality. In a multivariable model, HIV infection was not associated with an increased risk of death among Caucasians (hazard ratio 1.03, 95% confidence interval 0.91-1.16) but HIV/HCV co-infection (1.48, 1.18-1.87) was. In the same model for non-Caucasians, both HIV infection (1.44, 1.37-1.52) and HIV/HCV co-infection (1.71, 1.60-1.84) were significantly associated with higher mortality. A secondary analysis using propensity scores yielded similar results. Median follow-up for the reference group was 645 days (interquartile range 230-1323), 772 days (276-1623) for the HIV+ group and 777 days (334-1665) for the co-infected group. Thus, in the contemporary era of widespread antiretroviral use, HIV infection remains associated with a significant reduction in dialysis survival for non-Caucasians while HIV/HCV co-infection is associated with impaired survival regardless of race or ethnicity. Hence, interventions to improve the care for these vulnerable populations are needed.
引用
- Sawinski D, Forde KA, Locke JE, et al. Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice. Kidney Int. 2017. PMID: 29107361. doi:10.1016/j.kint.2017.08.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。